Biotech: Pressemitteilungen - Kategorie - Seite 171

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Titan Pharmaceuticals Announces Third Quarter 2012 Financial Results

SOUTH SAN FRANCISCO, CA: Titan Management Team to Host Conference Call November 13 at 1:00pm ET / 10:00am PT ...

Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis

DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 11/11/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced an additional analysis of data from the pivotal Circadian Administration of Prednisone in Rheumatoid A ...

BASi Announces Extension of Mortgage Maturity

WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 11/09/12 -- (NASDAQ: BASI) announced today that it has negotiated a six month extension, until May 2013, on the maturity of its $5,787,000 mortgage that was orig ...

Reimbursement Intelligence: Payers Struggling to Manage Combination Use of Costly Prostate Cancer Therapies

MADISON, NJ: MADISON, NJ -- (Marketwire) -- 11/09/12 -- Forty-seven percent of US payers surveyed indicate they plan to tightly manage the use of combination therapies to treat prostate cancer, according to data ...

International Stem Cell Corp Announces Third Quarter 2012 Financial Results

CARLSBAD, CA: CARLSBAD, CA -- (Marketwire) -- 11/09/12 -- International Stem Cell Corporation (OTCQB: ISCO) () ("ISCO" or "the Company") a California-based biotechnology company focused on ther ...

FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 11/08/12 -- Diazyme Laboratories announced today that the U.S. Food and Drug Administration (FDA) has granted Diazyme 510(k) clearance to market its Cystatin C POC Te ...

ProMetic to Report Third Quarter 2012 Financial Results and Hold Conference Call/Webcast

LAVAL, QUEBEC, CANADA: LAVAL, QUEBEC, CANADA -- (Marketwire) -- 11/08/12 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic" or the "Corporation") today announced that it will report its financial re ...

Sunshine Heart to Present at Upcoming Investor Conferences

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA -- (Marketwire) -- 11/08/12 -- Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that the company is scheduled to present corporate updates at the f ...

Mobius Therapeutics(TM) Announces Assignment of HCPCS Code for Mitosol(R)

ST. LOUIS, MO: CMS Assigns Code for Billing Medicare, Private Insurance ...

Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China

PISCATAWAY, NJ: PISCATAWAY, NJ -- (Marketwire) -- 11/08/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced two oral presentations at the 2nd Annual Symposium of Drug Delivery Systems-2012, which is bei ...

Cornerstone Therapeutics Acquires Exclusive U.S. Rights to Chiesi Farmaceutici S.p.A.'s BETHKIS(R) (Tobramycin Inhalation Solution)

CARY, NC: CARY, NC -- (Marketwire) -- 11/08/12 -- Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and related specialty markets, today announced it ...

Cornerstone Therapeutics Reports Third Quarter 2012 Financial Results

CARY, NC: CARY, NC -- (Marketwire) -- 11/08/12 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX)Net product sales increased 49% year over yearNet income increased tenfold year over yearIntegration of EKR Therape ...

MethylGene Presents MGCD265 Data at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 11/08/12 -- MethylGene Inc. (TSX: MYG) today announced that data for the clinical-stage Met/VEGFR inhibitor MGCD265, was presented at the 24th EORTC-NCI-AACR Symp ...

TiGenix: Business Update & Financial Highlights for Q3 of 2012

LEUVEN, BELGIUM: LEUVEN, BELGIUM -- (Marketwire) -- 11/08/12 -- (EURONEXT BRUSSELS: TIG)TiGenix NV (EURONEXT BRUSSELS: TIG), the European leader in cell therapy, gives an update of its business activities and provid ...

New Thinking Needed for an Age-Old Disease

BOSTON, MA: Leading Alzheimer's Scientist Calls for a Change in Direction by Focusing on Tau Tangles to Halt or Slow Disease Progression ...

Sarepta Therapeutics Announces Third Quarter 2012 Financial Results and Recent Corporate Developments

CAMBRIDGE, MA: Positive 48-Week Results From Phase IIb DMD Study Supports Eteplirsen's Further Development, Regulatory and Manufacturing Activities; Strong Financial Position With Current Cash Balance of $57.4 ...

Alethia Biotherapeutics Receives Notice of a Decision to Grant European Patent for its Siglec-15 Bone Antiresorptive

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 11/07/12 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies announced today ...

Cornerstone Therapeutics Announces Alastair McEwan as Chief Financial Officer

CARY, NC: CARY, NC -- (Marketwire) -- 11/07/12 -- (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and related specialty markets, announced today the app ...

China Pharma Holdings, Inc. to Report Third Quarter of Fiscal Year 2012 Financial Results on November 15, 2012

HAIKOU CITY, CHINA: HAIKOU CITY, CHINA -- (Marketwire) -- 11/07/12 -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), which develops, manufactures, and markets specialty pharmaceutical products ...


Seite 171 von 255:  « ..  170 171 172  173  174  175  176  177  178  179  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z